Press Releases
February 18, 2025
NOTICE TO DISREGARD -- LCX
Indeterminate
GlobeNewswire, Inc.
February 11, 2025
LCX Strengthens Ties with Cardano Ecosystem, Launches Token Sale for Profila’s $ZEKE Token
Indeterminate
GlobeNewswire, Inc.
January 24, 2025
xPortal Acquires Alphalink to Drive Innovation at the Intersection of AI and Crypto
Indeterminate
GlobeNewswire, Inc.
July 24, 2025
Premier League star investigated over liking anti-LGBTQ footage
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
April 8, 2025
OilXCoin's Prospectus Secures First Regulatory Approval For A Very Unique Security Token Backed by Oil & Gas
Indeterminate
GlobeNewswire, Inc.
March 28, 2025
Legacy Network Powers Up Education With Major Blockchain Move – $LGCT Set To Become Global Currency Of Learning
Indeterminate
GlobeNewswire, Inc.
February 27, 2025
German Blockchain & AI Week 2025: Agenda BEAM – 'Bridging European and Asian Markets'
Indeterminate
GlobeNewswire, Inc.
September 24, 2025
Press Statement by the Global Governance Group (3G) on its Eighteenth Ministerial Meeting on 24 September 2025
Gov't Institution
Singapore Ministry of Foreign Affairs
Owner: Singaporean Government
September 23, 2025
QOC Exchange Launches QOC Prime, QOC Plus, and QOC Max Apps in Europe
Indeterminate
GlobeNewswire, Inc.
June 15, 2025
EU Defends Schengen as Border Controls Mount Across Bloc
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
June 14, 2025
EU Reach Forty Years of Schengen Agreement
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
January 14, 2025
Beam Global Announces EV ARC™ System Meets CE Mark Compliance
Indeterminate
GlobeNewswire, Inc.
June 6, 2025
European Commission Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy
Indeterminate
GlobeNewswire, Inc.
April 23, 2025
Opterro, Inc. and Polytec GmbH Announce Strategic Distribution Agreement Across Eight European Countries
Neutral
EIN Presswire
May 8, 2025
Ligand Reports First Quarter 2025 Financial Results
Indeterminate
GlobeNewswire, Inc.
April 1, 2025
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above
Indeterminate
GlobeNewswire, Inc.